两种方式吸入布地奈德联合异丙托溴铵治疗急性感染性喉炎效果比较

肖晶晶,农 华,韩 琳,张健梅

武警医学 ›› 2017, Vol. 28 ›› Issue (2) : 143-145.

PDF(659 KB)
PDF(659 KB)
武警医学 ›› 2017, Vol. 28 ›› Issue (2) : 143-145.
论著

两种方式吸入布地奈德联合异丙托溴铵治疗急性感染性喉炎效果比较

  • 肖晶晶1,农 华2,韩 琳1,张健梅1
作者信息 +

Comparison of clinical efficacy of air compression atomizing inhalation and ultrasonic atomizing inhalation with budesonide combined with ipratropium bromide for patients with acute infectious laryngitis

  • XIAO Jingjing1, NONG Hua2, HAN Lin1, and ZHANG Jianmei1
Author information +
文章历史 +

摘要

目的 比较经空气压缩雾化吸入与超声雾化吸入布地奈德联合异丙托溴铵治疗急性感染性喉炎的临床疗效,以及对患者白细胞介素-4(interleukin-4)和免疫球蛋白E(immunoglobulin E,IgE)水平的影响。方法 选取2015-01至2016-06接受治疗的120例急性感染性喉炎患者作为研究对象,按照随机数字表法随机分为对照组60例和观察组60例。常规治疗基础上,所有患者均给予布地奈德联合异丙托溴铵雾化吸入治疗。对照组患者给予空气压缩雾化吸入治疗,观察组患者给予超声雾化吸入治疗。疗程结束后,比较对照组和观察组患者临床疗效、临床症状改善时间及血清IL-4、IgE水平。结果 临床疗效显示,观察组患者治疗总有效率明显高于对照组(95.0% vs 83.3%,P<0.05)。与对照组相比,观察组咳嗽、声音嘶哑、喉鸣等临床症状改善时间显著缩短[(3.3±0.8)d vs (4.2±1.0) d,(3.5±0.6)d vs (4.3±1.2) d,(6.4±0.9)d vs (7.9±1.4) d,P均<0.05]。治疗后,与对照组相比,观察组患者血清IL-4、IgE水平明显降低[(7.24±1.83)ng/L vs (15.19±2.36) ng/L,(50.43±9.62)μg/L vs (82.25±10.45)μg/L,P均<0.05]。结论 对于急性感染性喉炎,与空气压缩雾化吸入布地奈德联合异丙托溴铵治疗相比,超声雾化吸入治疗总有效率高,临床症状改善时间短,血清IL-4、IgE降低更明显,具有更显著优势。

Abstract

Objective To compare the curative efficacy of budesonide in combination with ipratropium bromide administrated by air compression atomizing inhalation and ultrasonic atomizing inhalation respectively in patients with acute infectious laryngitis and its effects on interleukin-4 (IL-4) and immunoglobulin E (IgE).Methods 120 patients with acute infectious laryngitis who received therapy in our hospital from January 2015 to June 2016 were selected as subjects. According to the random number table, those patients were randomly divided into the control group (n=60) and the observation group (n=60). Besides conventional treatments, all patients were treated with budesonide in combination with ipratropium bromide administrated by atomizing inhalation. The control group was given air compression atomizing inhalation, while the observation group was given ultrasonic atomizing inhalation. Then, the curative efficacy, time taken by improvement of clinic symptoms and levels of serum IL-4, IgE were compared between the two groups.Results The total therapeutic efficacy rate in the observation group was statistically higher than that in the control group (95.0% vs 83.3%, P<0.05). In comparison with the control group, the time taken by improvement of cough, hoarseness and laryngeal stridor in the observation group was statistically shorter respectively [(3.3±0.8) d vs (4.2±1.0) d, (3.5±0.6)d vs (4.3±1.2) d, (6.4±0.9)d vs (7.9±1.4) d, all P<0.05)]. After the treatment, levels of serum IL-4 and IgE in the observation group were statistically lower than those in the control group [(7.24±1.83) ng/L vs (15.19±2.36) ng/L, (50.43±9.62) μg/L vs (82.25±10.45) μg/L, both P<0.05)].Conclusions For patients with acute infectious laryngitis, ,ultrasonic atomizing inhalation has not only a higher total therapeutic efficacy rate, shorter improvement time of clinic symptoms and lower levels of IL-4, IgE than budesonide in combination with ipratropium bromide administrated by air compression atomizing inhalation, but also some other advantages.

关键词

空气压缩雾化吸入 / 超声雾化吸入 / 布地奈德 / 异丙托溴铵 / 急性感染性喉炎 / 白细胞介素-4 / 免疫球蛋白E

Key words

air compression atomizing inhalation / ultrasonic atomizing inhalation / budesonide / ipratropium bromide / acute infectious laryngitis / interleukin-4 / immunoglobulin E

引用本文

导出引用
肖晶晶,农 华,韩 琳,张健梅. 两种方式吸入布地奈德联合异丙托溴铵治疗急性感染性喉炎效果比较[J]. 武警医学. 2017, 28(2): 143-145
XIAO Jingjing, NONG Hua, HAN Lin, and ZHANG Jianmei. Comparison of clinical efficacy of air compression atomizing inhalation and ultrasonic atomizing inhalation with budesonide combined with ipratropium bromide for patients with acute infectious laryngitis[J]. Medical Journal of the Chinese People Armed Police Forces. 2017, 28(2): 143-145
中图分类号: R767.11   

参考文献

[1] Jolliffe D A, Griffiths C J, Martineau A R.Vitamin D in the prevention of acute respiratory infection: systemic review of clinical studies[J].J Steroid Biochem,2013(136):321-329.
[2] 施 弦.布地奈德联合干扰素雾化吸入治疗小儿急性感染性喉炎疗效分析[J].浙江中医药大学学报,2012,36(5):529-531.
[3] 王陈裕,华 刚,楼寿增,等.3%高渗盐水联合复方异丙托溴铵治疗幼儿毛细支气管炎的临床研究[J].中国临床药理学杂志,2014,30(2):122-124.
[4] King S, Glanville J, Sanders M E, et al. Effectiveness of probiotics on the duration of illness in healthy children and adults who develop common acute respiratory infectious conditions: a systemic review and meta-analysis[J]. Brit J Nutr,2014,112(1):41-54.
[5] 周少宏,王君霞,戴永利.布地奈德混悬液雾化吸入在儿童急性喉炎、喉气管支气管炎中的疗效观察[J].中国急救复苏与灾难医学杂志,2014,9(6):503-505.
[6] Ninbovorl J,Sawatdee S,Srichana T.Factors affecting the stability and performance of ipratropium bromide; fenoterol hydrobromide pressurized-metered dose inhalers[J]. AAPS Pharm Sci Tech,2013,14(4): 1294-1302.
[7] 赵明德.布地奈德雾化吸入治疗小儿轻度急性感染性喉炎的临床疗效观察[J].儿科药学杂志,2012,18(7):26-28.
[8] 周艳梅,李 清,张有为,等.氨溴索联合利巴韦林经空气压缩泵雾化吸入治疗细支气管炎疗效观察[J].中国全科医学,2011,14(32):3751-3752.
[9] 魏晓萍.喉腔滴药和超声雾化加音频治疗306例慢性喉炎的疗效观察[J].重庆医学,2011,40(1):75-76.
[10] Joo Y H, Lee S S, Han K D, et al. Association between chronic laryngitis and particulate matter base on the korea national health and nutrition examination survey 2008-2012[J]. Plos One,2015,10(7):78-79.
[11] 薛国昌,任明星,周静月,等.感染性喉炎和痉挛性喉炎患儿血清中IL-4、IFN-γ和IgE水平检测的临床意义[J].新医学,2014,45(1):49-52.
[12] 任明星,薛国昌,周静月,等.痉挛性喉炎患儿血清白细胞介素-4、γ干扰素和免疫球蛋白E水平变化的意义[J].中华实用儿科临床杂志,2014,29(4):286-288.
[13] 李晓娜,李玉杰,黄 炜,等.布地奈德对小儿感染性喉炎的疗效及IL-4、IFN-γ和IgE水平的影响[J].中国妇幼保健,2015,30(30):5194-5196.

PDF(659 KB)

Accesses

Citation

Detail

段落导航
相关文章

/